Evidence map›Paper›PMID 32341058›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2020

Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy.

Tiffany C Blair, Shelly Bambina, Alejandro F Alice, Gwen F Kramer, Terry R Medler, Jason R Baird, Miranda L Broz, Garth W Tormoen, Victoria Troesch, Marka R Crittenden and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Tiffany C BlairMolecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR 97239.ORCID 0000-0002-9136-4736
Shelly BambinaEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213.
Alejandro F AliceEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213.ORCID 0000-0003-3970-0293
Gwen F KramerEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213.ORCID 0000-0002-5362-5181
Terry R MedlerEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213.ORCID 0000-0002-9956-2630
Jason R BairdEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213.
Miranda L BrozBristol-Myers Squibb, Redwood City, CA 94063; and.
Garth W TormoenEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213.
Victoria TroeschEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213.
Marka R CrittendenEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213.ORCID 0000-0002-6403-765X
Michael J GoughEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213; michael.gough@providence.org.ORCID 0000-0002-5575-0074
Providence Portland Medical Center · USBristol-Myers Squibb (Germany) · DEOregon Health & Science University · US

Funding

High dose radiation therapy to direct immune responses to pancreatic cancerR01CA182311 · NCI · PROVIDENCE PORTLAND MEDICAL CENTER · PI GOUGH, MICHAEL JAMES · 2014 to 2023
$3.6M
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.R01CA208644 · NCI · PROVIDENCE PORTLAND MEDICAL CENTER · PI CRITTENDEN, MARKA · 2016 to 2020
$1.9M
Rewiring the myeloid cell response to adjuvants to improve tumor controlR01CA244142 · NCI · PROVIDENCE PORTLAND MEDICAL CENTER · PI GOUGH, MICHAEL JAMES · 2020 to 2024
$1.9M
NCI NIH HHS R01 CA182311NCI NIH HHS R01 CA208644NCI NIH HHS R01 CA244142
6 · The paper itself

Abstract

Radiation therapy is capable of directing adaptive immune responses against tumors by stimulating the release of endogenous adjuvants and tumor-associated Ags. Within the tumor, conventional type 1 dendritic cells (cDC1s) are uniquely positioned to respond to these signals, uptake exogenous tumor Ags, and migrate to the tumor draining lymph node to initiate cross-priming of tumor-reactive cytotoxic CD8

Indexed as

Adjuvants, ImmunologicAnimalsAntigens, NeoplasmCD8-Positive T-LymphocytesCell Line, TumorCell MovementCross-PrimingDendritic CellsImmunotherapy, AdoptiveLymph NodesMiceMice, Inbred C57BLMice, TransgenicNeoplasmsPoly I-CRadiotherapyAdjuvants, ImmunologicAntigens, NeoplasmPoly I-C

Identifiers

PMID32341058
PMCPMC7571541
OpenAlexW3017600170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.